CHU de Charleroi

Charleroi 6042

0 studies enrolling now · 6 studies all time

What they study most

Atrial Fibrillation, Bleeding, Coronary Artery Disease, Heart Failure, Rheumatoid Arthritis, Stroke, Venous Thromboembolism

Studies at this site

• CHAMPION-AF Clinical Trial — Running, not enrolling
• RESOLUTE ONYX Post-Approval Study — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) — Completed
• RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism — Completed
• A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT) — Stopped early